semaglutide compounding lawsuit Novo takes action against unlawful sales of Ozempic, Wegovy Novo Nordisk sues Hims &

In case further glycemic control is still needed, the dose can be augmented to 1.8 mg daily

It has therefore been postulated that the administration of molecules capable of mimicking the action of GLP-1 and/or GIP could reproduce this incretin effect and thus stimulate insulin production and improve glycemic control in type 2 diabetics

Malpractice and Insurance Exclusions Medical malpractice insurance policies often contain specific exclusions for non-FDA approved drugs or experimental therapies. If a patient suffers an adverse event (e.g., overdose due to incorrect syringe dosing, infection from non-sterile compound) from a compounded GLP-1, the prescribing physician may find themselves uninsured for the claim

They can also be cheaper than brand-name medications

GLP-1s are typically prescribed at a higher dose for obesity than for diabetes